Evolution of Chronic Inflammatory Skin Diseases
- Inflammatory Skin Disease
At a glance
- Phase
- Phase not stated
- Study type
- Observational
- Sponsor
- Fondazione Policlinico Universitario Agostino Gemelli IRCCS
- Enrolment target
- 5,000
- Started
- 1 July 2026
- Main results due
- July 2030
- Study sites
- 1
- Registry updated
- 25 September 2026
Can you take part?
- Aged 12 years and over.
- Open to any sex.
- You need the condition being studied — healthy volunteers are not accepted.
These are the headline rules only. Every study has a longer list, and whether you are eligible is decided by the research team at the site — never by this page.
Read the full eligibility criteria
Inclusion Criteria: * Age ≥12 years. * Patients with a confirmed clinical diagnosis of atopic dermatitis (AD), prurigo nodularis (PN), psoriasis (PSO), chronic hand eczema (CHE), or hidradenitis suppurativa (HS) attending the dermatology outpatient clinics of Fondazione Policlinico Universitario A. Gemelli IRCCS. * Availability of clinical data at baseline and at subsequent follow-up visits performed according to routine clinical practice. Exclusion Criteria: * Age \<12 years; absence of the minimum required data (treatment start date and at least one follow-up visit with a clinical score). * Refusal or inability to understand and sign the informed consent form.
What this study is about
In the sponsor’s own words, from the registry.
monocentric retrospective-prospective observational study evaluating the clinical evolution of common chronic inflammatory skin diseases, including atopic dermatitis, psoriasis, prurigo nodularis, chronic hand eczema, and hidradenitis suppurativa. The study will collect demographic, clinical, therapeutic, and validated clinimetric data from patients aged ≥12 years. Its primary aim is to describe changes in disease severity over time. Secondary objectives include identifying demographic, clinical, and treatment-related predictors of moderate-to-severe disease and unfavorable outcomes. Data will cover a 7-year retrospective period and a 10-year prospective follow-up.
Study sites(1)
Fondazione Policlinico Agostino Gemelli IRCCS
Rome, Italy
Recruiting
Showing 1 of 1 sites. 1 of the 1 site on this study is recruiting right now — a site can stop enrolling while the study as a whole is still open.
Source: ClinicalTrials.gov record NCT07708896. Trialion does not run this study, is not paid to refer anyone to it, and cannot enrol you. Eligibility is always decided by the research team at the site.
Not the right study?
Answer three questions and see the studies recruiting near you, in plain language.
Find a study for me